Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil. - Tsuchiya CT; Kim HS; Maximo MF; Ramos LA (Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2014)